Web28 Nov 2024 · Strand Therapeutics Raises $45M in Series A1 Funding. USA. Published on November 28, 2024. Strand Therapeutics, a Boston, MA-based programmable mRNA company, raised $45M in Series A1 funding. Web29 Nov 2024 · Strand Therapeutics, the programmable mRNA company developing curative therapies for cancer and other diseases, today announced it has added an additional $45M to its Series A financing round, bringing the total amount raised in the Series A to $97 million. New investor FPV led the round, with participation from Eli Lilly and Company, …
Strand Therapeutics - Funding, Financials, Valuation, Investors
WebView Strand Therapeutics (www.strandtx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more. ... BOSTON--(BUSINESS WIRE)-- #VC--Strand Therapeutics Announces Series A1 Bringing Total Oversubscribed Round to US$97 Million. Nov 28, … WebStrand Therapeutics is an early-stage biotechnology company utilizing synthetic biology to genetically program mRNA to deliver truly revolutionary immunotherapies. Building on the idea of creating smart therapies based on Boolean logic circuits, Strand was started by biological engineers working together at MIT who were seeking to apply the concept of … csv to db file
This Synthetic Bio Startup Raised $52 Million To Make Tumors
WebStrand Therapeutics is a next-generation biotechnology company committed to transforming the lives of patients by developing first-in-class programmable mRNA therapeutics. ... Potentum Partners, Camford Capital, Playground Global, and others. The company has added an additional $45M to its Series A round on Nov 28, 2024. This is an … Web23 Jun 2024 · CAMBRIDGE, MA, USA I June 23, 2024 I Strand Therapeutics, a privately held developer of next-generation, programmable mRNA therapeutics for cancer immunotherapy and other diseases, today announced that the company raised $52 million in an oversubscribed Series A financing round syndicated by Redmile Group, BeiGene, Ltd., and … Web12 Apr 2024 · Strand Therapeutics Overview Update this profile Founded 2024 Status Private Employees 102 Latest Deal Type Series A Latest Deal Amount $96.7M Investors 15 General Information Description Provider of biotechnology services intended to create gene therapies powered by synthetic biology. csv to epw converter